Licensed Practical Nurse in Hope, AR Accepting Medicare

23 Licensed Practical Nurse nurses found. Showing 21 - 23

Christie Latonya Ware-jones, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 715 Harris St, Hope, AR 71801 Phone: 307-202-3823

Phillis Lanora Johnson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 707 E Greenwood, Hope, AR 71801 Phone: 870-777-9800    Fax: 870-777-9811

Resheda Annette Warren, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 707 E Greenwood St, Hope, AR 71801 Phone: 870-777-9800    Fax: 870-777-9811

News Archive

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that Plexur M® (moldable), a bone-polymer biocomposite built upon the Company's proprietary Plexur® technology platform, has been approved for use by 50 U.S. hospitals to date. The Company expects to receive additional approvals as Plexur M continues to gain mindshare among surgeons.

NMT releases new device for treatment of post-operative nausea

Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics.

COVID-19 antibodies can protect against reinfection for at least eight months

A new study offers hope that recovered patients from COVID-19 are largely immune to reinfection for at least eight months.

Spending $5 billion a year on tobacco cessation for 25 years would profoundly improve the health of Americans

An article published in the Sept. 8, 2005 New England Journal of Medicine sheds new light on the $130 billion smoking cessation plan proposed in the Department of Justice suit against the tobacco companies.

Advanced Life Sciences seeks government funding for development of Restanza antibiotic

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional government funding for development of its novel, once-daily antibiotic, Restanza.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)